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The potential role of protein kinase C (PKC)-promoted phos-
phorylation has been examined in the G-protein-regulated
inositol lipid signalling pathway. Incubation of [$#P]P
i
-labelled
turkey erythrocytes with either the P2Y
"
receptor agonist 2-
methylthioadenosine triphosphate (2MeSATP) or with PMA
resulted in a marked increase in incorporation of $#P into the G-
protein-activated phospholipase C PLC-βT. Purified PLC-βT
also was phosphorylated by PKC in itro to a stoichiometry
(mean³S.E.M.) of 1±06³0±2 mol of phosphate}mol of PLC-βT.
Phosphorylation by PKC was isoenzyme-specific because, under
identical conditions, mammalian PLC-β2 also was phosphoryl-
ated to a stoichiometry near unity, whereas mammalian PLC-β1
was not phosphorylated by PKC. The effects of PKC-promoted
phosphorylation on enzyme activity were assessed by recon-
stituting purified PLC-βT with turkey erythrocyte membranes
devoid of endogenous PLC activity. Phosphorylation resulted in
a decrease in basal activity, AlF
%
−-stimulated activity, and activity
INTRODUCTION
Activation of G-protein-coupled receptors by neurotransmitters,
hormones and chemoattractants elicits intracellular responses
from a small number of effectors, including the membrane






glycerol, which in turn leads to the mobilization of intracellular
Ca#+ and the activation of protein kinase C (PKC) [1]. The
coding sequences of four mammalian isoenzymes (PLC-β1, PLC-
β2, PLC-β3 and PLC-β4), a Meleagris (turkey) isoenzyme, a
Xenopus isoenzyme and two Drosophila isoenzymes (NorpA and
dPLC-β) of PLC-β have been identified [2].
Agonist-induced desensitization is an important regulatory
process in the inositol lipid signalling pathway [3]. PMA-
promoted activation of PKC also results in the desensitization of
the PLC signalling response by modification of components
downstream of the G-protein-coupled receptor [4–7]. PKC
apparently does not phosphorylate G-proteins of the G
q
family
[8]. However, evidence for the PKC-promoted phosphorylation
of signalling effector enzymes [9–16], including PLC-β isoenzymes
[17–20], has been observed. Although direct demonstration of a
change in enzyme activity was not reported, agonist- and PMA-
induced desensitization of the platelet-activating factor receptor-
coupled inositol lipid signalling response in RBL-2H3 cells was
shown to occur simultaneously with phosphorylation of PLC-β3
[20]. Direct phosphorylation by PKC of PLC-β purified from
bovine brain (presumably PLC-β1) also has been reported [17],
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stimulated by 2MeSATP plus guanosine 5«-[γ-thio]triphosphate
in the reconstituted membranes. The decreases in enzyme ac-
tivities were proportional to the extent of PKC-promoted
phosphorylation. Catalytic activity assessed by using mixed
detergent}phospholipid micelles also was decreased by up to
60% by phosphorylation. The effect of phosphorylation on G
q
α-
stimulated PLC-βT in reconstitution experiments with purified
proteins was not greater than that observed on basal activity
alone. Taken together, these results illustrate that PKC
phosphorylates PLC-βT in io and to a physiologically relevant
stoichiometry in itro. Phosphorylation is accompanied by a
concomitant loss of enzyme activity, reflected as a decrease in
overall catalytic activity rather than as a specific modification of
G-protein-regulated activity.
Key words: inositol phospholipid, G proteins, signal trans-
duction.
but the functional consequence of phosphorylation on enzyme
activity was not established. Litosch [18] also observed phos-
phorylation in itro of partly purified PLC-β1 by PKC and
reported that phosphorylation resulted in a decrease in Ca#+-
dependent catalytic activity [19]. However, purification of PLC-
β1 diminished PKC-dependent effects on catalytic activity,
suggesting that an unidentified cofactor was mediating the effect
of PKC on PLC-β1.
The turkey erythrocyte has proved a useful model for the
study of receptor-regulated inositol lipid signalling. All three of





[23,24] and turkey PLC-βT [25–27], of this signalling
pathway have been identified and their coding sequences cloned.
Desensitization of the inositol lipid signalling pathway in turkey
erythrocytes has been characterized. Activation of turkey eryth-
rocyte PKC indirectly by P2Y receptor agonists or directly by
PMA resulted in decreases in agonist- and guanosine 5«-[γ-
thio]triphosphate (GTP[S])-stimulated PLC activity in mem-
branes prepared from these cells [28,29]. The decreased re-
sponsiveness to GTP[S] suggested that the regulation of inositol
lipid signalling occurred at a level downstream of the P2Y
receptor, i.e. through the inactivation of either Gα
""
or PLC-βT.
In this study we tested the hypothesis that PKC-promoted
phosphorylation of PLC-βT serves as a mechanism for
desensitization of inositol lipid signalling in turkey erythrocytes
and provide direct evidence for PKC-mediated phosphorylation
leading to a change in PLC-βT catalytic activity.
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MATERIALS AND METHODS
Materials
PKC purified from rat brain was obtained from Boehringer
Mannheim (Indianapolis, IN, U.S.A.). PKC isoforms α, β1, β2
and γ were purchased from Calbiochem (San Diego, CA,
U.S.A.). PtdIns4P and PtdIns(4,5)P
#
were purified from bovine
brain Folch fraction I as described previously [25]. [$H]PtdIns4P
and [$H]PtdIns(4,5)P
#
were purified from [$H]inositol-labelled
turkey erythrocyte membranes as described previously [30].
Phosphatidylethanolamine (PtdEtn) (bovine heart), 1,2-dioleoyl-
sn-glycerol (DOG) and phosphatidylserine (PtdSer) (brain) were
purchased from Avanti Polar Lipids (Alabaster, AL, U.S.A.).
Dulbecco’s modified Eagle’s medium (DMEM) was purchased
from Gibco}BRL (Grand Island, NY, U.S.A.). 5-Bromo-4-
chloroindol-3-yl phosphate and Nitro Blue Tetrazolium colo-
rimetric substrates were obtained from Bio-Rad (Hercules, CA,
U.S.A.). Nickel-nitriloacetic acid (Ni-NTA) agarose resin was
purchased from Qiagen (Chatsworth, CA, U.S.A.).
Protein purification
PLC-βT was purified from Sf9 cells after baculovirus-mediated
















were obtained from Dr. John
Hepler and Dr. Alfred Gilman (University of Texas Southwestern





purified from Sf9 cell membranes after baculovirus-mediated









baculovirus constructs were used to
infect Sf9 cells simultaneously; heterotrimeric G
i
was purified by
using Ni-NTA affinity chromatography, and purified Gβγ was
eluted with A1F
%
− as described [8]. Turkey Gα
""
was purified
from turkey erythrocyte membranes as described previously [30].
Kinase reaction
PLC-β1, PLC-β2 and PLC-βT (2 pmol}10 µl) were incubated
with 10 µl-units (unless otherwise indicated) of PKC (rat brain
mix or purified α, β1, β2 or γ isoforms) for 10 min at 30 °C in a





, 200 µM dithiothreitol (DTT), 200 µM ATP, lipid acti-
vators [100 µg}ml PtdSer and 20 µg}ml DOG initially solubilized
by sonication in 10 mM Tris (pH 7±5)}10 mM CHAPS] and
(1–5)¬10' c.p.m. [γ-$#P]ATP. Reactions were stopped with the
addition of an equal volume of 2¬Laemmli sample buffer [31].
Incorporation of $#P was quantified after protein separation by
SDS}PAGE [7.5% (w}v) gel], excision of the phosphorylated







OH at 55 °C, and liquid-scintillation quantification of radio-
activity in the solubilized gel slice.
For the assay of PLC-βT activity after phosphorylation, [γ-
$#P]ATP was omitted from the kinase reaction and the reaction
was stopped by dilution 1:50 in ice-cold Hepes}BSA buffer
[10 mM Hepes (pH 7±0)}1 mg}ml BSA}200 nM Calyculin
A}10 mM β-glycerophosphate]. PLC-βT activity was assayed
immediately after the kinase reaction.
Assay of catalytic activity of PLC-βT
The catalytic activity of PLC-βT was quantified with
[$H]PtdIns(4,5)P
#
as described previously [30]. PLC-βT (25 µl ;
1–10 ng) in 10 mM Hepes, pH 7±0, containing 2 mg}ml fatty-
acid-free BSA was added to 75 µl of reaction mixture on ice to
give final concentrations of the following components : 50 µM
PtdIns(4,5)P
#
(unless otherwise indicated), 10000–15000 c.p.m.
[$H]PtdIns(4,5)P
#
, 0±5% sodium cholate, 10 mM Hepes, pH 7±4,





. Reactions were incubated for 10 min at 30 °C
and were terminated by the addition of 375 µl of chloroform}
methanol}HCl (40:80:1, by vol.). Chloroform (125 µl) and 0±1 M
HCl (125 µl) were added, the samples were mixed vigorously,
and aqueous and organic phases were separated by centrifugation
for 5 min at 2000 g. [$H]Ins(1,4,5)P
$
release was quantified by
scintillation counting of 350 µl of the upper phase.
Reconstitution of PLC-βT with turkey erythrocyte membranes
Receptor and G-protein regulation of purified PLC-βT was
quantified by the reconstitution of purified PLC-βT and substrate
phospholipids with turkey erythrocyte membranes. Turkey
erythrocytes were collected, washed as described previously [21]
and resuspended in an equal volume of lysis buffer [20 mM
Hepes (pH 7±0)}5 mM MgCl
#
}2 mM EGTA}150 mM NaCl}
200 µM PMSF}200 µM benzamidine}10 µM tosylphenylalanyl-
chloromethane (Tos-Phe-CH
#
Cl; ‘TPCK’)}2 µM pepstatin
A}10 mM β-glycerophosphate}50 mM NaF]. Resuspended tur-
key erythrocytes (2 ml) were vortex-mixed vigorously in the
presence of 1 g of glass beads (0±45 mm) for four bursts of 30 s
interspersed with cooling on ice [32]. The lysate}glass bead
mixture was centrifuged at 5000 g for 3 min to pellet beads and
unbroken cells. The supernatant was collected in a fresh tube on
ice, an additional 1 ml of lysis buffer was added to the glass
beads, and the vortex-mixing and centrifugation steps repeated
to complete erythrocyte lysis. Glass beads were washed a final
time with 1 ml of lysis buffer and allowed to settle for 5 min
without centrifugation, the supernatant was then pooled with the
previous supernatant fraction. The pooled supernatant was
centrifuged at 36000 g for 20 min and the resultant pellet was
collected as a crude membrane fraction. Membranes were
resuspended in 1 ml of lysis buffer and incubated with 46 µ-units
of DNase for 5 min at room temperature, centrifuged at 36000 g
for 20 min at 4 °C, and assayed for protein concentration. The
final membrane suspension (25 µg}15 µl) was in DB buffer
[20 mM Hepes (pH 7±0)}1 mM MgCl
#
}100 mM NaCl}2 mM
DTT}200 µM PMSF}200 µM benzamidine}10 nM microcystin-
LR}10 mM β-glycerophosphate] and the membranes were stored
at ®80 °C. Phospholipid substrate was prepared as a mixture of
PtdIns4P (5 nmol per assay), PtdEtn (25 nmol per assay) and
[$H]PtdIns4P (10000–15000 c.p.m. per assay) dried under ni-
trogen and resuspended in 20 mM Hepes, pH 7±0. Phospholipid
substrate was mixed with thawed membranes at a 2:3 ratio (v}v)
and incubated on ice for 1 h before assay. The resultant radio-
labelled membranes (25 µl) were mixed with 25 µl of 4¬
membrane assay buffer [80 mM Hepes (pH 7±2)}80 mM





] and with 25 µl of 20 mM Hepes, pH 7±0,
or, for receptor or G-protein activation, with 25 µl of 4¬AlF
%
−
buffer (80 µM AlCl
$
}40 mM NaF diluted in 20 mM Hepes,
pH 7±0), 25 µl of 400 µM GTP[S] or 400 µM GTP[S] plus 40 µM
2-methylthioadenosine triphosphate (2MeSATP). Samples were
preincubated for 3 min at 30 °C and then 25 µl of PLC-βT
(2±5–20 ng per assay) was added and incubation was continued
for a further 20 min at 30 °C. The reactions were terminated, and
[$H]Ins(1,4)P
#
accumulation was quantified as described above.
All assays were performed in triplicate ; the number of repetitions
are indicated in Figure legends.
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Reconstitution of PLC-βT with purified G-protein subunits
Activation of PLC-βT by G-protein subunits was quantified by
using detergent-free phospholipid vesicles reconstituted with
purified proteins. PtdIns(4,5)P
#
(2 nmol per assay), PtdSer
(2 nmol per assay), PtdEtn (8 nmol per assay) and [$H]-
PtdIns(4,5)P
#
(10000–15000 c.p.m. per assay) were dried under
nitrogen and resuspended in dialysis buffer [20 mM Hepes
(pH 7±4)}1 mM MgCl
#
}2 mM DTT}100 mM NaCl}200 µM
PMSF}200 µM benzamidine] plus 0±8% sodium cholate. G-
protein subunits (0±04–100 ng) were diluted in 10 µl per assay of
dialysis buffer plus 0±8% sodium cholate and mixed 3:2 (v}v)
with resuspended phospholipids. The G-protein}phospholipid
mixture was dialysed overnight against 2 litres of dialysis buffer
(4 °C, in the dark) ; 25 µl of the resultant unilamellar phospholipid
vesicles was mixed with 25 µl of 4¬reconstitution assay buffer





], 25 µl of PLC-βT [25 ng diluted in 20 mM
Hepes (pH 7±0)}2 mg}ml BSA (fatty-acid-free)] and with 25 µl of
20 mM Hepes, pH 7±0, or, for stimulation of Gα subunits, with
25 µl of 4¬AlF
%
− buffer. Reactions were incubated at 30 °C for
10 min, terminated, and then [$H]Ins(1,4,5)P
$
accumulation was
quantified as described above.
[32P]Pi labelling in vivo and immunoprecipitation
Washed turkey erythrocytes were labelled overnight in air}CO
#
(19:1) with stirring (60 rev.}min) at 37 °C in phosphate-free
DMEM (4 ml}ml of packed erythrocytes) with [$#P]P
i
(1±2
mCi}ml of packed erythrocytes). [$#P]P
i
-labelled erythrocytes
were centrifuged for 5 min at 500 g, resuspended in DMEM
buffered with 20 mM Hepes, pH 7±4 (5 ml}ml of packed eryth-
rocytes) and equilibrated for 10 min at 37 °C. Drugs were added
as indicated and incubation at 37 °C continued for 20 min.
Erythrocytes were centrifuged again for 3 min at 500 g and lysed
as described above. The supernatant fraction obtained after
centrifugation at 36000 g was retained as a cytosolic fraction and
used for the immunoprecipitation of PLC-βT as described below.
Turkey erythrocyte cytosol (1 ml) was incubated for 1 h at
4 °C with 1 µl of anti-(PLC-βT serum (no. 858, antiserum
against native PLC-βT [33]) on an inverting rotator. Protein
A–agarose (50 µl of a 50% suspension in 20 mM Tris}HCl,
pH 7±4) was added and incubation continued for 1 h at 4 °C.
Immunoprecipitation samples were centrifuged at 15000 g for
15 s, the supernatant was aspirated and the Protein A–agarose
pellet was washed twice with 1 ml of immunoprecipitation buffer
[20 mM Tris (pH 7±4)}200 µM PMSF}200 µM benzamidine}2
µM pepstatin A}10 µM Tos-Phe-CH
#
Cl}50 mM NaF}10 mM
β-glycerophosphate}10 nM microcystin-LR] plus 1% (w}v) BSA
followed by a final 1 ml wash with immunoprecipitation buffer
only. The pellet resulting from Protein A–agarose immuno-
precipitation was resuspended in 50 µl of Laemmli sample buffer
and incubated at 85 °C for 10 min before electrophoresis.
Immunoprecipitated proteins were resolved by SDS}PAGE
[7±5% (w}v) gel] by the method of Laemmli [31]. Proteins were
transferred electrophoretically to nitrocellulose and exposed to a
PhosphorImager screen (Molecular Dynamics) for quantification
of $#P incorporation by comparison with a $#P standard curve
exposed simultaneously. PLC-βT was detected immunologically
by polyclonal antiserum no. 246 produced against denatured
PLC-βT [33]. In brief, nitrocellulose was blocked in TBS [20 mM
Tris}HCl (pH 7±5)}500 mM NaCl] plus 3% (w}v) BSA and
incubated for 1 h with a 1:500 dilution of antibody no. 246 in
TBS plus 1% (w}v) BSA. Nitrocellulose was washed with TBS
plus 0±05% (v}v) Tween 20 and incubated for 1 h with alkaline
phosphatase-conjugated goat anti-(rabbit IgG) antibody (1:2000
dilution) in TBS plus 1% (w}v) BSA. Proteins were detected
by incubation with alkaline phosphatase colorimetric sub-
strates (5-bromo-4-chloroindol-3-yl phosphate and Nitro Blue
Tetrazolium). Quantification of PLC-βT immunoprecipitated
for stoichiometric calculations was accomplished by a digital
densitometric comparison with a standard curve of purified
PLC-βT on the same blot.
Calculation of the specific radioactivity of the γ-phosphate of
[32P]ATP in vivo
Calculation of the specific radioactivity of the γ-phosphate of
[$#P]ATP from [$#P]P
i
-treated turkey erythrocytes was determined
by the method of Garrison et al. [34]. In brief, 1 ml of washed
and packed turkey erythrocytes was radiolabelled overnight with
[$#P]P
i
as described above. $#P-labelled erythrocytes (1–10 µl)
were lysed by the addition of 0±5 ml of 5% trichloroacetic acid
on ice. Samples were centrifuged at 750 g for 15 min to remove
precipitated material, and the supernatant was extracted three
times with 3 ml of diethyl ether to remove trichloroacetic acid.
The samples were neutralized with 10 µl of 1 M Tris}HCl,
pH 8±0. The ATP content of the samples was determined by
luciferin}luciferase assay as described by Watt et al. [35]. The
intracellular ATP concentration obtained by luciferin}luciferase
assay after measuring the mean turkey erythrocyte cell volume
(134 fl) was 1±2 mM. This value is in good agreement with the
previously published value of 1 mM ATP in turkey erythrocytes
[36].
$#P-labelled nucleotides were separated on a C
")
column by
HPLC as described by Lazarowski et al. [37] ; radioactivity co-
migrating with the ATP pool was quantified by scintillation
spectrometry. Half of the $#P-labelled sample was incubated with
3 units}ml hexokinase in high-glucose DMEM for 30 min at
37 °C to hydrolyse ATP completely to ADP and P
i
. The specific
radioactivity of the γ-phosphate of ATP was calculated as the
difference in free [$#P]P
i





prelabelled turkey erythrocytes with the
PKC activator PMA resulted in an increase in phosphorylation
of PLC-βT (Figure 1). The effect of PMA was concentration-
dependent and was not mimicked by 4α-phorbol 12,13-
didecanoate, a phorbol ester that does not activate PKC. The
Figure 1 Phosphorylation of PLC-βT in vivo
Turkey erythrocytes were treated as described in the Materials and methods section with
vehicle, 10 µM 2MeSATP, the indicated concentrations of PMA, or 4α-phorbol 12,13-
didecanoate (Pdd) for 20 min at 37 °C. Cells were lysed and PLC-βT was immunoprecipitated
as described in the Materials and methods section. Immunoprecipitated proteins were separated
by SDS/PAGE and were detected by immunoblotting with anti-(PLC-βT) antibodies (A) or
exposed for 32P detection with a PhosphorImager (B). The 135 kDa protein species co-migrating
with purified PLC-βT is presented from a representative experiment with similar results obtained
at least three times.
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Figure 2 Phosphorylation of PLC-βT in vitro
Top panel : PLC-βT (2 pmol) was incubated with PKC (various concentrations) for 10 min at
30 °C as described in the Materials and methods section. Phosphate incorporation was detected
with a PhosphorImager after SDS/PAGE (top panel, inset) or quantified as described in the
Materials and methods section and is presented as mol of phosphate incorporated per mol of
PLC-βT. Representative results are shown and similar results were obtained in four
experiments. Middle panel : PLC-PLC-βT (βT), PLC-β2 (β2) and PLC-β1 (β1) were incubated
for 10 min at 30 °C in kinase reactions in the presence (­) or absence (®) of 10 µ-units
(µU) of PKC. Proteins were subjected to SDS/PAGE and detected by Coomassie staining (A),
or 32P incorporation was detected with a PhosphorImager screen (B). Bottom panel : PLC-βT
and PLC-β1 were incubated for 10 min at 30 °C in kinase reactions with 10 µ-units of
individual PKC isoforms α, β1, β2 and γ. Proteins were subjected to SDS/PAGE and 32P
incorporation was detected with a PhosphorImager screen. Bands corresponding to the 135 kDa
PLC-βT protein and the 150 kDa PLC-β1 proteins are presented and results are representative
of those from two (bottom panel) or three (middle panel) experiments.
stoichiometry of phosphate incorporation into PLC-βT in intact
erythrocytes incubated in the presence of PMA (calculated as
described in the Materials and methods section) was 0±35 mol of
phosphate}mol of immunoprecipitated PLC-βT (average of two
separate experiments). Incubation of turkey erythrocytes with
the P2Y receptor agonist 2MeSATP also increased the
phosphorylation of PLC-βT, although to approx. 50% of the
level of PMA-induced phosphorylation (Figure 1).
Having established that PLC-βT was phosphorylated in io
after the activation of PKC, we examined directly the capacity of
purified brain PKC to phosphorylate PLC-βT. Purified PLC-βT
was incubated with PKC in the presence of DOG and PtdSer.
PKC-promoted phosphorylation of PLC-βT was observed and
increased with time of incubation (results not shown) or con-
centration of PKC (Figure 2, top panel). Maximal phosphate
Figure 3 Reconstitution of PLC-βT with turkey erythrocyte membranes
Turkey erythrocyte membranes devoid of endogenous PLC-β activity were prepared as
described in the Materials and methods section. Upper panel : purified PLC-βT (various
concentrations) was added to turkey erythrocyte membranes and incubated in the presence of
10 mM Hepes, pH 7±0, containing vehicle (+), 100 µM GTP[S] (E) or 100 µM GTP[S] plus
10 µM 2MeSATP (_) for 20 min at 30 °C. Lower panel : purified PLC-βT (10 ng),
preincubated in the absence (open bars) or presence (filled bars) of 10 µ-units of PKC, was
added to turkey erythrocyte membranes and incubated in the presence of vehicle (basal), Alf4−
or 100 µM GTP[S] (GTPγS) plus 10 µM 2MeSATP for 20 min at 30 °C. The activity of PLC-
βT is shown as pmol of Ins(1,4)P2 (IP2) released per mg of PLC-βT. Results are means³S.D.
for triplicate determinations and are representative of three experiments.
incorporation was achieved within 10 min at 30 °C with a
concentration of 1 µ-unit of PKC}µl of reaction. A stoichiometry
of phosphorylation (mean³S.E.M.) near unity (1±06³0±20 mol
phosphate}mol PLC-βT; n¯ 6) was obtained under optimal
conditions. Phosphorylation was minimal in the absence of PKC
(Figure 2, middle panel), indicating that little or no endogenous
kinase activity was present in the preparation of PLC-βT.
Phosphorylation also was PLC-β isoenzyme-specific. Whereas
PLC-βT and mammalian PLC-β2 were phosphorylated to a
stoichiometry of approx. 1 mol}mol, under identical reaction
conditions PLC-β1 remained essentially unphosphorylated (Fig-
ure 2, middle panel).
The preparation of brain PKC consisted of a mixture of PKC
isoforms. However, a comparison of the capacity of several Ca#+-
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Figure 4 Extent of phosphorylation-dependent effects on PLC activity
PLC-βT was phosphorylated to various stoichiometries (right axis, broken line, U) by
incubation with the indicated concentrations of PKC for 10 min at 30 °C. Phosphorylated PLC-
βT (20 ng) was then reconstituted with turkey erythrocyte membranes assayed in the presence
of vehicle (D), 100 µM GTP[S] (^) or 100 µM GTP[S] plus 10 µM 2MeSATP (*) for
20 min at 30 °C and activity was quantified as µmol of Ins(1,4)P2 (IP2) released/min per mg
of PLC-βT (left axis, solid lines). Results are means³S.D. for triplicate determinations ; similar
results were obtained in two experiments. Abbreviation : µU, µ-units.
dependent and diacylglycerol-dependent PKC isoforms (α, β1,
β2 and γ) to phosphorylate PLC-β1 and PLC-βT suggested
that little specificity for substrate exists among the PKC iso-
forms (Figure 2, bottom panel). All four purified PKC isoforms
phosphorylated PLC-βT to a stoichiometry near unity (0±7–
0±9 mol}mol), whereas none of these PKC isoforms phos-
phorylated PLC-β1 to a stoichiometry greater than 0±03 mol}
mol. The brain PKC preparation was therefore used in all
subsequent experiments.
A reconstitution assay was established to determine directly
the effect of phosphorylation on the activity of PLC-βT. The
assay involved the quantification of the activity of purified PLC-
βT after reconstitution with turkey erythrocyte membranes
devoid of endogenous PLC-β activity but apparently retaining a
full complement of receptor and G-protein activators. As
illustrated in Figure 3 (upper panel), inositol lipid hydrolysis was
proportional to the amount of exogenous PLC-βT reconstituted.
Activity of the reconstituted enzyme also was stimulated by
GTP[S] alone or by the P2Y
"
receptor agonist 2MeSATP in the
presence of GTP[S]. Phosphorylation of PLC-βT to a stoi-




stimulated phospholipase activity (Figure 3, lower panel)
compared with non-phosphorylated PLC-βT. The phos-
phorylation-induced decrease in PLC activity occurred at all
concentrations of PLC-βT tested (results not shown). Import-
antly, not only were phosphorylation-promoted decreases in
G-protein-stimulated and receptor-stimulated activity of phos-
phorylated PLC-βT observed, but similar decreases in basal PLC
activity occurred.
Basal, GTP[S]-stimulated, and 2MeSATP-plus-GTP[S]-stimu-
lated PLC activities also were quantified in reconstitution assays
performed with PLC-βT phosphorylated to various stoichio-
Figure 5 Catalytic activity of PLC-βT after phosphorylation
Upper panel : PLC-βT (concentrations indicated) was incubated in the absence (*) or presence
(+) of 10 µ-units of PKC as described in the Materials and methods section. Activity was
quantified [pmol/min Ins(1,4,5)P3 (IP3) released] by using phospholipid/detergent mixed
micelles for 10 min at 30 °C. Similar results were obtained in three experiments. Lower panel :
PLC-βT was phosphorylated to various stoichiometries (left axis, solid line, +) by incubation
with 10 µ-units of PKC for the indicated durations at 30 °C. Phosphorylated PLC-βT (2 ng) was
then mixed with phospholipid/detergent mixed micelles for 10 min at 30 °C and activity was
quantified as µmol of Ins(1,4,5)P3 released/min per mg of PLC-βT (right axis, broken line, D).
Activity results shown (both panels) are means³S.D. for triplicate determinations ; similar
results were obtained in three experiments.
metries (0–0±9 mol}mol) by PKC. As illustrated in Figure 4, the
phosphorylation-dependent decrease in PLC-βT activity was
proportional to the concentration of PKC in the kinase reaction
and to the amount of phosphate incorporated. By accumulating
results over eight experiments, the decreases inGTP[S]-stimulated
or 2MeSATP-plus-GTP[S]-stimulated PLC-βT activities were
fully accounted for by a decrease in basal PLC-βT activity, i.e.
the maximal PKC-promoted decrease in activity was essentially
the same in all three activity measurements.
The phosphorylation-promoted decrease in basal PLC-βT
activity observed in membrane reconstitution assays was
examined more directly by measuring catalytic activity with
inositol lipid substrate}Na+ cholate mixed micelles. The catalytic
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Figure 6 Phosphorylation-induced change in substrate dependence of
PLC-βT
PLC-βT (2 ng), preincubated in the absence (*) or presence (+) of 10 µ-units of PKC, was
incubated with phospholipid/detergent mixed micelles ; the bulk PtdIns(4,5)P2 (PIP2) con-
centration was varied as indicated. Reactants were incubated for 10 min at 30 °C and PLC-βT
activity was quantified as µmol of Ins(1,4,5)P3 (IP3) produced/min per mg of PLC-βT. A replot
of the data by the method of Hanes is shown in the inset. Apparent Km and Vmax values were
207 µM and 91 µmol/min per mg respectively for samples with PKC, and 102 µM and
108 µmol/min per mg respectively for samples without PKC. Similar results were obtained four
times.
activity of PLC-βT against substrate in mixed detergent micelles
also was decreased after phosphorylation in the presence of PKC
(Figure 5, upper panel). The decrease in catalytic activity of
PLC-βT was dependent on the time of incubation with PKC
(Figure 5, lower panel) and the concentration of PKC (results
not shown) and achieved a maximal decrease in activity of
approx. 60% of control levels.
The effects of PKC-promoted phosphorylation on Ptd-
Ins(4,5)P
#
substrate concentration dependence were determined
in assays with phospholipid}detergent mixed micelles. The
difference in catalytic activity between phosphorylated and
non-phosphorylated PLC-βT was greatest at low substrate
concentrations and diminished at higher substrate concentrations
(Figure 6), suggesting that phosphorylation decreased enzyme
affinity for substrate rather than inhibited maximal reaction
velocity. Single-site kinetics were observed for unphosphorylated
PLC-βT, as has been demonstrated previously [38]. In contrast,
more complex substrate kinetics, indicated by the non-linear
Hanes regression curve (Figure 6, inset), were observed after
phosphorylation of PLC-βT. No change in Ca#+ dependence was
detected on PKC-promoted phosphorylation of PLC-βT (results
not shown).
The effect of PKC-induced phosphorylation of PLC-βT on its
regulation by G-protein subunits also was studied after
reconstitution of the enzyme with purified G
q
α in unilamellar
phospholipid vesicles. PKC-promoted phosphorylation resulted
in a decrease in PLC-βT-catalysed activity both in the absence




α (Figure 7, upper panel).
This finding was consistent with the phosphorylation-dependent
decrease in basal activity observed in the phospholipid}detergent
Figure 7 Reconstitution of phosphorylated PLC-βT with purified G-protein
subunits
PLC-βT (20 ng) was preincubated in the absence (D) or presence (E) of 10 µ-units of PKC
as described in the Materials and methods section. Upper panel : control and phosphorylated
PLC-βT were reconstituted with the indicated concentrations of Gqα (Gαq) as described in the
Materials and methods section. Lower panel : control (open bars) and phosphorylated PLC-βT
(filled bars) were reconstituted with the indicated concentrations of Gβγ as described in the
Materials and methods section. Incubations were for 10 min at 30 °C ; the activity of PLC-βT
was quantified as µmol of Ins(1,4,5)P3 (IP3) produced/min per mg of PLC-βT. Results are
means³S.D. for triplicate determinations and are representative of three experiments.
mixed-micelle assay. Surprisingly, a phosphorylation-dependent
decrease in PLC-βT activity was not detected in assays with Gβγ
(Figure 7, lower panel), suggesting that the activation of PLC-βT
by Gβγ surmounts the decrease in basal activity induced by the
phosphorylation of PLC-βT.
DISCUSSION
Guanine nucleotide-stimulated PLC activity is markedly
attenuated in membranes prepared from PMA-pretreated cells,
which has led to the hypothesis that the PKC-promoted modi-
fication of G
q
or PLC-β is an important regulatory component of
inositol lipid signalling [3,6]. A similar phenomenon occurs in
turkey erythrocytes [29] ; we have shown here that PLC-βT is
phosphorylated to a physiologically important stoichiometry in
io as a consequence of activation of PKC. Moreover, purified
PLC-βT is an excellent substrate for four Ca#+-dependent and
# 1999 Biochemical Society
263Phosphorylation of PLC-β
diacylglycerol-dependent PKC isoforms; the results provide
direct demonstration of an effect of phosphorylation on the
activity of a PLC-β isoenzyme.
The membrane reconstitution assay applied in this study
permitted the quantification in situ of the activities of
phosphorylated PLC-βT under conditions that make no
assumptions a priori about the mode by which phosphorylation
regulates enzyme activity. The phosphorylation-induced decrease
in basal as well as P2Y
"
-receptor- and guanine nucleotide-
stimulated PLC activities in the reconstitution assay strongly
suggest that the overall catalytic activity of PLC-βT is decreased
as a consequence of phosphorylation. This view is supported by
a similar phosphorylation-induced decrease in activity measured
in an assay of catalytic activity with detergent and phospholipid
micelles. Results from studies in which PKC-phosphorylated
PLC-βT was reconstituted with G
q
α also are consistent with this
conclusion because no effect occurred on G
q
α-stimulated PLC-
βT activity beyond that measured in the absence of G-protein
and attributable to a decrease in PLC-βT catalytic activity.
Therefore we conclude that phosphorylation inhibits the overall
catalytic activity of PLC-βT rather than selectively modifying
regulation by, for example, a G-protein subunit, as has been
suggested for the regulation of PLC-β2 by cAMP-dependent
protein kinase [39].
The lack of effect of PKC-promoted phosphorylation of PLC-
βT on Gβγ-stimulated activity is puzzling. The activating effects
of Gβγ apparently overcome the effect of phosphorylation on
basal catalytic activity. Although α-subunits of the G
q
family of
G-proteins are probably more important than is Gβγ for
activation of PLC-β in the pertussis toxin-insensitive inositol
lipid signalling response, this idea has not been formally proven.
Turkey Gα
""
was purified on the basis of its capacity to activate
PLC-βT [23] but PLC-βT is also very sensitive to stimulation by
Gβγ subunits [40]. The pertussis toxin-sensitive signalling path-
way of the Xenopus oocyte has been proposed to utilize Gβγ
instead of Gα subunits for the activation of PLC-βX [41,42].
None of the assays currently available for measurement of
PLC-β activity provide a complete portrait of the physiological
regulation of PLC-β enzymes. Reconstitution assays with purified
G-proteins lack G-protein modulators such as regulators of G-
protein signalling proteins [43] and must utilize non-hydrolysable
GTP analogues for detectable activation of Gα proteins. PLC-β
enzymes possess an intrinsic G-protein GTPase-stimulating ac-
tivity [44,45], suggesting a dynamic regulation in io involving
GTP–G
q
α stimulation of PLC-β and PLC-β-promoted deacti-
vation of GTP-G
q
α that cannot be measured in the presence of
hydrolysis-resistant GTP analogues. Our assays utilizing turkey
erythrocyte membranes, which were presumed to contain a full
complement of signalling proteins such as receptor, G-protein α
and βγ subunits and RGS proteins, might nevertheless lack the
critical cytoskeletal components involved in positioning sig-
nalling molecules for efficient signal transduction. The effects of
the phosphorylation of PLC-β on interaction with all of these
potential intracellular regulators of PLC-β activity remains to be
investigated. Therefore the phosphorylation-promoted decrease
in catalytic activity reported here might underestimate both the
scope and the magnitude of PKC-mediated attenuation of
inositol lipid responses in io.
PLC-βT is 69% identical with mammalian PLC-β2. Whether
these isoenzymes should be considered specific homologues is
unclear. Both are very sensitive to activation by Gβγ, whereas





was illustrated in Figure 2, PLC-β2 also is phosphorylated in the
presence of PKC to a stoichiometry of approx. 1:1. PKC-
promoted phosphorylation of PLC-β is isoenzyme-specific be-
cause PLC-β1 was not a PKC substrate under the conditions
used in these experiments. The significance of the selectivity of
phosphorylation of PLC-β isoenzymes in the desensitization of
the inositol lipid signalling pathway is unknown but the oc-
currence of isoenzyme-specific phosphorylation establishes some
intriguing possibilities.
In contrast with the current results, Litosch [19] recently
reported a decrease in Ca#+-stimulated PLC-β1 activity after
phosphorylation by PKC in itro that could be blocked by
preincubation of the enzyme with Gβγ. Preincubation of PLC-
βT with Gβγ does not block the phosphorylation of PLC-βT by
PKC (K. J. Stanig, T. M. Filtz and T. K. Harden, unpublished
work). Incubation times that result in a loss of PLC-βT activity
under our conditions were required to achieve PLC-β1
phosphorylation in the study by Litosch [19], regardless of the
PKC isoform tested. An unidentified cofactor was also necessary
to achieve maximal PKC-promoted effects on the activity of
PLC-β1 [18]. Ali et al. [20] recently reported that PLC-β3 is
phosphorylated downstream of PKC activation in PMA-
stimulated or platelet activating factor-stimulated RBL-2H3
cells. Whether this is a direct phosphorylation by PKC and
whether this phosphorylation is responsible for a loss of inositol
lipid signalling response is yet to be established. Liu and Simon
[39] have reported that coexpression in COS-7 cells of PLC-β2
with cAMP-dependent protein kinase, but not PKCα, PKCβ or
PKCε, results in a decrease in inositol phosphate response
to overexpressed Gβγ but not a decrease in the response to
overexpressed G
q
α. Whether a protein kinase A-promoted effect
occurred on the basal catalytic activity of the expressed PLC-β2
was not possible to ascertain from their studies.
Although the results reported here demonstrate directly a
phosphorylation-induced decrease in the activity of a PLC-β
isoenzyme, the phosphorylation of G-proteins or G-protein-
related proteins, e.g. regulators of G-protein signalling (RGS)-
proteins, remains a possibility as a mechanism for regulation of
inositol lipid signalling. In other studies with turkey erythro-
cyte membranes devoid of endogenous PLC-β activity we have
separated the effects of phosphorylation on PLC-βT activity
from the effects on membrane-bound regulators of PLC-βT.
These preliminary experiments have revealed that the treatment
of turkey erythrocytes with PMA also results in a decreased
capacity of GTP[S] to promote the activity of exogenously
reconstituted PLC-β1 in membranes prepared from these cells
(M. L. Cunningham, T. M. Filtz and T. K. Harden, unpublished
work). Thus desensitization of the inositol lipid signalling path-
way in io might result from dual modification of membrane-
bound G-protein activators and PLC-β. The turkey erythrocyte
model should prove useful in quantifying the relative contribution
of phosphorylation of each of the protein cohorts in the inositol
lipid signalling pathway.
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